TS
FLXN

Twin Securities’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Twin Securities’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-17,100
Closed -$460K – 26
2017
Q1 		$460K Buy
+17,100
New +$349K 0.08% 24

Other funds holding FLXN

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Twin Securities's FLXN Position: Q2 2017 in Review

Twin Securities sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2017, closing a stake of 30,000 shares — an estimated $807K sold.

Twin Securities first reported a position in FLXN in Q1 2017 and held it in 1 quarter. The position peaked at $807K in Q1 2017. 100 funds tracked by Wall St. Rank hold FLXN as of Q2 2017.

  • Twin Securities reported no remaining Flexion Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Twin Securities sold 30,000 Flexion Therapeutics, Inc. shares in Q2 2017, an estimated $807K.
  • Twin Securities first reported a position in Flexion Therapeutics, Inc. in Q1 2017 and held it in 1 quarter.
  • Twin Securities's Flexion Therapeutics, Inc. position peaked at $807K in Q1 2017.
  • 100 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2017.

Based on Twin Securities's 13F filing for Q2 2017, filed 14 Aug 2017.